|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/03/16 Organovo Holdings, Inc. 10-Q 9/30/16 49:4.5M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 346K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
11: R1 Document and Entity Information HTML 38K
12: R2 Condensed Consolidated Balance Sheets HTML 94K
13: R3 Condensed Consolidated Balance Sheets HTML 27K
(Parenthetical)
14: R4 Unaudited Condensed Consolidated Statements of HTML 65K
Operations
15: R5 Unaudited Condensed Consolidated Statements of HTML 92K
Cash Flows
16: R6 Unaudited Condensed Consolidated Statements of HTML 21K
Cash Flows (Parenthetical)
17: R7 Description of Business and Summary of Significant HTML 102K
Accounting Policies
18: R8 Derivative Liability HTML 52K
19: R9 Stockholders' Equity HTML 218K
20: R10 Commitments and Contingencies HTML 44K
21: R11 Concentrations HTML 23K
22: R12 Recent Accounting Pronouncements HTML 26K
23: R13 Subsequent Events HTML 26K
24: R14 Description of Business and Summary of Significant HTML 132K
Accounting Policies (Policies)
25: R15 Description of Business and Summary of Significant HTML 73K
Accounting Policies (Tables)
26: R16 Derivative Liability (Tables) HTML 46K
27: R17 Stockholders' Equity (Tables) HTML 200K
28: R18 Commitments and Contingencies (Tables) HTML 34K
29: R19 Description of Business and Summary of Significant HTML 86K
Accounting Policies - Additional Information
(Detail)
30: R20 Description of Business and Summary of Significant HTML 31K
Accounting Policies - Estimated Fair Values of
Liabilities Measured on Recurring Basis (Detail)
31: R21 Description of Business and Summary of Significant HTML 32K
Accounting Policies - Activity for Liabilities
Measured at Estimated Fair Value Using
Unobservable Inputs (Detail)
32: R22 Derivative Liability - Additional Information HTML 33K
(Detail)
33: R23 Derivative Liability - Assumptions Used to Value HTML 32K
Derivative Liabilities at End of Each Reporting
Period (Detail)
34: R24 Stockholders' Equity - Additional Information HTML 175K
(Detail)
35: R25 Stockholders' Equity - Summary of Company's HTML 30K
Restricted Stock Award Activity (Detail)
36: R26 Stockholders' Equity - Summary of Company's HTML 41K
Restricted Stock Unit Activity (Detail)
37: R27 Stockholders' Equity - Additional Information 1 HTML 53K
(Detail)
38: R28 Stockholders' Equity - Summary of Stock Option HTML 53K
Activity (Detail)
39: R29 Stockholders' Equity - Fair Value of Employee HTML 32K
Stock Options (Detail)
40: R30 Stockholders' Equity - Additional Information 2 HTML 94K
(Detail)
41: R31 Stockholders' Equity - Fair Value of Employee HTML 37K
Stock Purchase Plan (Detail)
42: R32 Stockholders' Equity - Summary of Warrant Activity HTML 45K
(Detail)
43: R33 Stockholders' Equity - Common Stock Reserved for HTML 31K
Future Issuance (Detail)
44: R34 Commitments and Contingencies - Additional HTML 44K
Information (Detail)
45: R35 Commitments and Contingencies - Future Minimum HTML 37K
Rental Payments Required under Operating Leases
that have Initial or Remaining Non-Cancelable
Lease Terms in Excess of One Year (Detail)
46: R36 Subsequent Events - Additional Information HTML 52K
(Detail)
48: XML IDEA XML File -- Filing Summary XML 86K
47: EXCEL IDEA Workbook of Financial Reports XLSX 58K
5: EX-101.INS XBRL Instance -- onvo-20160930 XML 1.23M
7: EX-101.CAL XBRL Calculations -- onvo-20160930_cal XML 98K
8: EX-101.DEF XBRL Definitions -- onvo-20160930_def XML 384K
9: EX-101.LAB XBRL Labels -- onvo-20160930_lab XML 776K
10: EX-101.PRE XBRL Presentations -- onvo-20160930_pre XML 658K
6: EX-101.SCH XBRL Schema -- onvo-20160930 XSD 112K
49: ZIP XBRL Zipped Folder -- 0001564590-16-027345-xbrl Zip 105K
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Organovo Holdings, Inc. (the “Company”) for the period ended September 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), I, Keith Murphy, Chairman of the Board, Chief Executive Officer and President and I, Craig Kussman, Chief Financial Officer of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
• |
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 3, 2016
|
/s/ Keith Murphy |
|
Chairman of the Board, Chief Executive Officer and President (Principal Executive Officer)
|
|
/s/ Craig Kussman |
|
Chief Financial Officer (Principal Financial and Accounting Officer)
|
A signed original of this written statement required by Section 906 has been provided to Organovo Holdings, Inc. and will be retained by Organovo Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Organovo Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/3/16 | 8-K | ||
| For Period end: | 9/30/16 | |||
| List all Filings | ||||